Supplementary Material Supplementary Materials
5-Aminolevulinic acid (ALA), 2',7'-dichlorofluorescein diacetate (DCFH-DA), 1,3-Diphenylisobenzofuran (DPBF), the PPARγ antagonist GW9662 and anti-LXR antibody were purchased from Sigma-Aldrich (St Louis, MO, USA). Singlet oxygen sensor green (SOSG) was obtained from Invitrogen (MA, USA). Protoporphyrin IX (PpIX) was purchased from Macklin Inc.
(Shanghai, China). Phorbol-12-myristate-13-acetate (PMA) was obtained from EMD Biosciences, Inc. (La Jolla, CA, USA). oxLDL, HDL and apoA1 were purchased from Union-Biology Co., Ltd. (Beijing, China). Total and free cellular cholesterol continuous cycle enzymatic colorimetric kits were purchased from Genmed Scientific, Inc. (Arlington, MA, USA). pHrodoTM Red SE was purchased from Molecular Probes (Carlsbad, CA, USA). X-tremeGENE siRNA Transfection Reagent and an In Situ Cell Death Detection Kit, POD, were purchased from Roche Applied Science (Lewes, UK). Antibodies against CD68, PPARγ, CD36, ABCA1, TGFβ and IL-10 were purchased from Abcam (Cambridge, UK). Antibodies against ABCG1, GADD153, MerTK, cytochrome c and β-actin were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Antibody against cleaved caspase 3 was purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-α smooth muscle actin (α-SMA) Antibody was purchased from Boster Biological Technology (Wuhan, China). Anti-TOM20 antibody was purchased from Bioss (Beijing, China). Anti-Mouse CD11b PerCP-Cyanine5.5 was purchased from Thermo Fisher Scientific (Beverly, MA, USA). Mouse IL-10 and TGFβ ELISA kits were obtained from NeoBioscience Technology Co., Ltd. (Shenzhen, China).
Supplementary Methods
Accumulation of ALA-PpIX in Mouse Atherosclerotic Plaque To determine time point at which ALA accumulated to the maximum in atherosclerotic plaque, apoE -/-mice were administered with ALA (60 mg/kg) into the caudal vein, and sacrificed at 0, 1, 2, 3, 4 and 6 h post ALA injection, respectively (n=6). Cryosections of aortic root were obtained for detecting ALA-PpIX in atherosclerotic plaques with fluorescence spectrometer (USB2000, Ocean Optics Inc., USA). Fluorescence spectra were excited by illumination of 405 nm violet light with a linewidth of 20 nm. Emission spectra from 450 to 830 nm were collected. Data were analyzed by the OriginLab OriginPro 7.0 software.
ALA-PpIX distribution analysis
In vivo, fresh-frozen sections of aortic root of apoE -/-mice were obtained for fluorescent detection of ALA-PpIX distribution by fluorescence microscope (Olympus, Tokyo, Japan) at 2 h following injection of ALA (60 mg/kg) into the caudal vein (n=6). Immunofluorescent staining of macrophages (anti-CD68), smooth muscle cells (anti-α-SMA) and mitochondria (anti-TOM20) was performed to detect ALA-PpIX distribution within plaques.
Histological assay
The systemic effects of ALA-SDT were evaluated with hematoxylin and eosin (H&E) staining. 1 Day after ALA-SDT treatment, tissues of apoE -/-mice were collected and embedded in paraffin. Then the sectioned slices were subjected to H&E staining according to routine histopathological methods.
ROS assessment in vivo
The levels of ROS within atherosclerotic plaques were assessed by the ROS indicator DCFH-DA. Briefly, fresh-frozen sections of apoE -/-mice aortic root were obtained immediately after ALA-SDT treatment. 10 µM DCFH-DA was added to the slide and incubated at 37°C for 30 min in the dark. The nuclei were counterstained with DAPI for 10 min. The cryosections were then washed carefully three times with PBS and observed under fluorescence microscopy at once. DCF fluorescence was measured at 488 nm excitation and 525 nm emission wavelengths.
ROS assessment in vitro
The in vitro ROS generation by SDT was estimated by DCFH-DA [1] , and singlet oxygen generation was estimated by SOSG [2] and DPBF [3] as described previously. Briefly, 10 μM DCFH-DA, 5 μM SOSG or 20 μM DPBF was added to water containing 0.5 mM or 1 mM PpIX respectively. The solution was exposed to ultrasound while being kept in the dark. After being exposed, the fluorescence intensity of DCF and SOSG was measured using a fluorescence microplate reader (Tecan, Switzerland; Ex/Em=488/525 nm and 504/525 nm respectively). DPBF was determined using the UV-vis spectrometer (Varian Australia Pty Ltd., Australia) by measuring absorbance at 413 nm. The ROS generation in foam cells by ALA-SDT treatment was estimated by DCFH-DA at 0, 0.5, 1, 2, 3, 4 h after the treatment. Briefly, foam cells were stained with 10 µM DCFH-DA at 37°C for 30 min in the dark. The nuclei were counterstained with Hoechst33342 for 10 min. Then the foam cells were observed under fluorescence microscopy at once. DCF was measured at 488 nm excitation and 525 nm emission wavelengths.
Lipid analysis
Mouse serum samples were collected prior to tissue harvest. The total cholesterol level in serum was measured enzymatically using a kit from Sigma Chemical Co.. 
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